Ken Rosenthal’s eminently reasonable position on Jeff Bagwell and steroids

37 Comments

Not sure why it’s so hard for Hall of Fame voters to get on board with the ideas that (a) it’s not fair to assume someone was on steroids when there is no evidence of it; and (b) Jeff Bagwell, on the merits, posted a Hall of Fame career. But considering it’s highly unlikely he’ll be inducted this year, a healthy number of voters have a hard time with those concepts.

Thank goodness for Ken Rosenthal, then.  I don’t agree with everything he says in his Hall of Fame column — what fun would that be? — but how anyone can disagree with this is beyond me.

When voting, one should only consider the facts at hand. If Bagwell is later revealed to have been a user, maybe I will stop voting for him, if he isn’t already in the Hall. There is little doubt that he is deserving otherwise, unless you’re somehow unimpressed by his .408 on-base percentage and .540 slugging mark, not to mention his baserunning, defense at first base and leadership of the Astros during his 15-year career … For now, all I know is one thing: I’m not withholding votes based on hearsay and innuendo.

Imagine.

RHP Fairbanks, Rays agree to 3-year, $12 million contract

tampa bay rays
Dave Nelson/USA TODAY Sports
0 Comments

ST. PETERSBURG, Fla. — Reliever Pete Fairbanks and the Tampa Bay Rays avoided arbitration when they agreed Friday to a three-year, $12 million contract that could be worth up to $24.6 million over four seasons.

The deal includes salaries of $3,666,666 this year and $3,666,667 in each of the next two seasons. The Rays have a $7 million option for 2026 with a $1 million buyout.

His 2024 and 2025 salaries could increase by $300,000 each based on games finished in the previous season: $150,000 each for 35 and 40.

Tampa Bay’s option price could increase by up to $6 million, including $4 million for appearances: $1 million each for 60 and 70 in 2025; $500,000 for 125 from 2023-25 and $1 million each for 135, 150 and 165 from 2023-25. The option price could increase by $2 million for games finished in 2025: $500,000 each for 25, 30, 35 and 40.

Fairbanks also has a $500,000 award bonus for winning the Hoffman/Rivera reliever of the year award and $200,000 for finishing second or third.

The 29-year-old right-hander is 11-10 with a 2.98 ERA and 15 saves in 111 appearances, with all but two of the outings coming out of the bullpen since being acquired by the Rays from the Texas Rangers in July 2019.

Fairbanks was 0-0 with a 1.13 ERA in 24 appearances last year after beginning the season on the 60-day injured list with a right lat strain.

Fairbanks made his 2022 debut on July 17 and tied for the team lead with eight saves despite being sidelined more than three months. In addition, he is 0-0 with a 3.60 ERA in 12 career postseason appearances, all with Tampa Bay.

He had asked for a raise from $714,400 to $1.9 million when proposed arbitration salaries were exchanged Jan. 13, and the Rays had offered for $1.5 million.

Fairbanks’ agreement was announced two days after left-hander Jeffrey Springs agreed to a $31 million, four-year contract with Tampa Bay that could be worth $65.75 million over five seasons.

Tampa Bay remains scheduled for hearings with right-handers Jason Adam and Ryan Thompson, left-hander Colin Poche, third baseman Yandy Diaz and outfielder Harold Ramirez.